Papers

5

Total Citations

144

H-Index

5

About

Panagiotis Balermpas is a leading radiation oncologist whose research centers on stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) for challenging, recurrent cancers. His major contributions include demonstrating the feasibility and efficacy of repeated in-field radiosurgery for locally recurrent brain metastases, a heavily treated patient cohort where his 2018 study has garnered 61 citations. He has also optimized SBRT for lung tumors by integrating robotic-guided motion compensation and mean gross tumor volume (GTV) dose optimization, with his 2018 work accumulating 30 citations. Balermpas’s investigations into breathing-motion-compensated robotic SBRT (29 citations) and hypo-fractionated SBRT for localized prostate cancer (16 citations) further underscore his commitment to precision, non-invasive treatments. Notably, he has explored the limits of re-irradiation, reporting on a patient with recurrent head and neck cancer who received a cumulative EQD2max exceeding 180 Gy—a testament to his willingness to push therapeutic boundaries. His work consistently refines dose delivery and patient selection, offering new hope for those with limited options. Balermpas’s research is essential reading for clinicians and physicists advancing stereotactic techniques in oncology.

Research Focus

Key Achievements

5
H-Index
5
Papers
144
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort
61 citations · 2018
📈 Most Prolific Year: 2018 (3 Papers)
🤝 Key Collaborators: 33
🏛 Institutions: Goethe University Frankfurt, SAPHIR Radiochirurgie, Klinikum Frankfurt Höchst

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago